Article Versions Notes

Zhou Y, Chung P-y, Ma JY-w, Lam AK-y, Law S, Chan K-w, Chan AS-c, Li X, Lam K-h, Chui C-h, et al. Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells. Biology. 2019; 8(4):75. https://doi.org/10.3390/biology8040075

Zhou, Yuanyuan, Po-yee Chung, Jessica Yuen-wuen Ma, Alfred King-yin Lam, Simon Law, Kwok-wah Chan, Albert Sun-chi Chan, Xingshu Li, Kim-hung Lam, Chung-hin Chui, and et al. 2019. "Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells" Biology 8, no. 4: 75. https://doi.org/10.3390/biology8040075

Zhou, Y., Chung, P. -y., Ma, J. Y. -w., Lam, A. K. -y., Law, S., Chan, K. -w., Chan, A. S. -c., Li, X., Lam, K. -h., Chui, C. -h., & Tang, J. C. -o. (2019). Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells. Biology, 8(4), 75. https://doi.org/10.3390/biology8040075